133 related articles for article (PubMed ID: 35700365)
1. Drug Induced Diabetes Mellitus in Pediatric Acute Lymphoblastic Leukemia: Approach to Diagnosis and Management.
Handattu K; Sharma LK; Vijayasekharan K; Bhat K V; Aroor S; Sudhanshu S
J Pediatr Hematol Oncol; 2022 Aug; 44(6):273-279. PubMed ID: 35700365
[TBL] [Abstract][Full Text] [Related]
2. A new onset drug induced diabetes mellitus presenting with diabetic ketoacidosis in a child undergoing treatment for B cell acute lymphoblastic leukemia. A case report and review of literature.
Sharma P; Vyas V; Didel S; Singh K
J Pediatr Endocrinol Metab; 2024 Apr; 37(4):367-370. PubMed ID: 38281148
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of metformin for therapy-induced hyperglycemia in children with acute lymphoblastic leukemia.
Bostrom B; Uppal P; Chu J; Messinger Y; Gandrud L; McEvoy R
J Pediatr Hematol Oncol; 2013 Oct; 35(7):504-8. PubMed ID: 23823111
[TBL] [Abstract][Full Text] [Related]
4. Safe and effective dosing of basal-bolus insulin in patients receiving high-dose steroids for hyper-cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy.
Brady V; Thosani S; Zhou S; Bassett R; Busaidy NL; Lavis V
Diabetes Technol Ther; 2014 Dec; 16(12):874-9. PubMed ID: 25321387
[TBL] [Abstract][Full Text] [Related]
5. Permanent insulin-dependent diabetes mellitus in a patient with acute lymphoblastic leukemia.
Akane Y; Yamamoto M; Igarashi K; Takebayashi A; Hori T
Pediatr Int; 2020 Mar; 62(3):403-405. PubMed ID: 32022381
[No Abstract] [Full Text] [Related]
6. Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administration.
Pollock NI; Flamand Y; Zhu J; Millington K; Stevenson K; Silverman LB; Vrooman LM; Cohen LE
Pediatr Blood Cancer; 2022 Jul; 69(7):e29505. PubMed ID: 34931744
[TBL] [Abstract][Full Text] [Related]
7. Atypical diabetes mellitus in children - when to suspect drug-induced diabetes. A case-based review of the literature.
A Okruszko M; Szabłowski M; Pochodowicz K; Taranta-Janusz K; Bossowski A; Głowińska-Olszewska B
Pediatr Endocrinol Diabetes Metab; 2022; 28(4):294-300. PubMed ID: 36106423
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia induced by chemotherapeutic agents used in acute lymphoblastic leukemia: report of three cases.
Wang YJ; Chu HY; Shu SG; Chi CS
Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jun; 51(6):457-61. PubMed ID: 8281494
[TBL] [Abstract][Full Text] [Related]
9. Retrospective Evaluation of Glycemic Control With Basal-Bolus or Neutral Protamine Hagedorn Insulin Regimens in Patients Receiving Continuous Enteral Nutrition Therapy in Medicine Wards.
Hijaze D; Szalat A
Nutr Clin Pract; 2017 Aug; 32(4):557-562. PubMed ID: 28760108
[TBL] [Abstract][Full Text] [Related]
10. Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy.
Majithia AR; Wiltschko AB; Zheng H; Walford GA; Nathan DM
J Diabetes Sci Technol; 2018 Jan; 12(1):76-82. PubMed ID: 28868899
[TBL] [Abstract][Full Text] [Related]
11. Addressing hyperglycemia from hospital admission to discharge.
Moghissi ES
Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
[TBL] [Abstract][Full Text] [Related]
12. Management of hyperglycemia in hospitalized noncritical patients.
Mikhail N
South Med J; 2013 Mar; 106(3):238-46. PubMed ID: 23462495
[TBL] [Abstract][Full Text] [Related]
13. Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
[TBL] [Abstract][Full Text] [Related]
14. Reliability of Inpatient CGM: Comparison to Standard of Care.
Price C; Ditton G; Russell GB; Aloi J
J Diabetes Sci Technol; 2023 Mar; 17(2):329-335. PubMed ID: 34911384
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia.
Vu K; Busaidy N; Cabanillas ME; Konopleva M; Faderl S; Thomas DA; O'Brien S; Broglio K; Ensor J; Escalante C; Andreeff M; Kantarjian H; Lavis V; Yeung SC
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):355-62. PubMed ID: 22658895
[TBL] [Abstract][Full Text] [Related]
16. L-asparaginase-induced abnormality in plasma glucose level in patients of acute lymphoblastic leukemia admitted to a tertiary care hospital of Odisha.
Panigrahi M; Swain TR; Jena RK; Panigrahi A
Indian J Pharmacol; 2016; 48(5):595-598. PubMed ID: 27721550
[TBL] [Abstract][Full Text] [Related]
17. Institution of basal-bolus therapy at diagnosis for children with type 1 diabetes mellitus.
Adhikari S; Adams-Huet B; Wang YC; Marks JF; White PC
Pediatrics; 2009 Apr; 123(4):e673-8. PubMed ID: 19254971
[TBL] [Abstract][Full Text] [Related]
18. Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia.
Baillargeon J; Langevin AM; Mullins J; Ferry RJ; DeAngulo G; Thomas PJ; Estrada J; Pitney A; Pollock BH
Pediatr Blood Cancer; 2005 Dec; 45(7):960-3. PubMed ID: 15700246
[TBL] [Abstract][Full Text] [Related]
19. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
20. Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
Diabetes Care; 2002 Dec; 25(12):2147-52. PubMed ID: 12453952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
